Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 5.81B 859M 749M 693M 649M 1.22B 81.03B 1.23B 8.24B 3.19B 39.9B 3.22B 3.16B 139B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 6.69B 988M 862M 797M 747M 1.4B 93.22B 1.41B 9.47B 3.67B 45.9B 3.71B 3.63B 159B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 day-1.84%
1 week-2.07%
Current month-7.19%
1 month-12.35%
3 months-16.31%
6 months-22.97%
Current year-2.07%
1 week 4.23
Extreme 4.23
4.54
1 month 4.23
Extreme 4.23
4.93
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.94
3 years 2.98
Extreme 2.98
9.22
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.83
Manager TitleAgeSince
Chief Executive Officer 56 02/04/2015
Director of Finance/CFO 41 29/12/2020
Corporate Officer/Principal 42 27/01/2014
Director TitleAgeSince
Chairman 56 27/03/2026
Director/Board Member 58 25/12/2007
Director/Board Member 42 27/01/2014
Date Insider Type Main position Quantity % Market Cap.
21/09/20Sell

Chairman

1,940,600 0.2495%
18/09/20Sell

Chairman

296,500 0.0381%
18/09/20Sell

Director

3,670,000 0.4719%
Change 5-day change 1-year change 3-year change Capi.($)
-1.84%-2.07%+1.91%-50.87% 860M
-0.98%-4.19%-12.39%-9.24% 12.78B
-1.84%-3.29%-34.79%-57.81% 4.77B
-3.47%-8.69%-12.79%-6.91% 4.34B
+0.29%+0.88%+15.02%-16.19% 3.81B
+0.47%-1.38%+6.15%-43.79% 3.71B
-1.30%-1.74%-5.85%-11.27% 3.53B
-0.07%-0.77%-9.39%-3.49% 3.11B
-0.71%+5.52%-4.62%-26.47% 2.38B
-1.61%-2.57%-14.38%+29.97% 1.68B
Average -1.11%-3.93%-7.11%-19.61% 4.1B
Weighted average by Cap. -1.08%-4.29%-9.35%-18.43%

Financials

2024 2025
Net sales 3.83B 565M 493M 456M 427M 800M 53.3B 806M 5.42B 2.1B 26.25B 2.12B 2.08B 91.16B 3.05B 450M 393M 363M 340M 637M 42.48B 642M 4.32B 1.67B 20.92B 1.69B 1.65B 72.65B
Net income 33.62M 4.97M 4.33M 4.01M 3.75M 7.03M 469M 7.09M 47.62M 18.44M 231M 18.65M 18.24M 801M -104M -15.42M -13.45M -12.44M -11.65M -21.82M -1.45B -21.99M -148M -57.22M -716M -57.88M -56.63M -2.49B
Net Debt 1.4B 207M 180M 167M 156M 293M 19.51B 295M 1.98B 768M 9.61B 777M 760M 33.37B 875M 129M 113M 104M 97.66M 183M 12.19B 184M 1.24B 480M 6B 485M 475M 20.84B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
18/06/26 4.260 ¥ -1.84% 9,528,924
17/06/26 4.340 ¥ -1.36% 8,379,700
16/06/26 4.400 ¥ -0.90% 5,168,100
15/06/26 4.440 ¥ -0.45% 6,307,050
12/06/26 4.460 ¥ +2.53% 8,378,869

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!